Recommendations
Below are the recommendations for improvements to patient safety that the PSC has made and the responses from the relevant organisations. Our expectation is that those organisations will respond within three months and we will publish those responses.
Recommendation One
The Patient Safety Commissioner recommends for NHS England to have a fully funded and resourced system for improving the safe use of the most potent teratogenic medications, through a National Quality Improvement Programme for Integrated Care Systems, starting with the safe use of sodium valproate. The Commissioner believes that this should be implemented by September 2024 for sodium valproate, before expanding to cover any medication with a Pregnancy Prevention Programme by September 2025.
In January NHS England accepted this recommendation. See the full response by clicking the button below.